Loading organizations...
Loading organizations...
Clinical stage biopharmaceutical company developing novel drugs.
Armetheon has raised $31.3M across 2 funding rounds.
Armetheon has raised $31.3M in total across 2 funding rounds.
Armetheon has raised $31.3M in total across 2 funding rounds.
Armetheon's investors include Capital TEN, Hercules BioVentures Partners, Larry Hsu, Stefan Roever, Amkey Ventures, CDIB Capital Group, iD SoftCapital Group, AshHill Investments, Atheneos Capital.
Armetheon has raised $31.3M across 2 funding rounds. Most recently, it raised $24.3M Series B in February 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 5, 2015 | $24.3M Series B | Capital TEN, Hercules BioVentures Partners | Larry Hsu, Stefan Roever, Amkey Ventures, CDIB Capital Group, iD SoftCapital Group |
| Aug 28, 2014 | $7.0M Series A | AshHill Investments, Hercules BioVentures Partners | Larry Hsu, Atheneos Capital |